Fig. 4

Correlation analyses between DC markers and clinical parameters. AST, ALT, total bilirubin, HCV RNA, HCV genotype, and IL-28B genotype were analyzed in order to verify possible correlations with circulating DC subsets markers before (Fig. 4a–c) and after iv-SIL treatment (Fig. 4d–g). DC markers at baseline were also correlated with clinical parameters at the end of iv-SIL treatment (Fig. 4h–i)